Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-25

Clinical Trial Update: Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating genistein to reduce side effects of superficial bladder cancer treatment have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Genistein (genistein)

Snippet

Sponsor: Emory University | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-07-25